NOX4

NADPH oxidase 4

Basic information

Region (hg38): 11:89324353-89498187

Links

ENSG00000086991NCBI:50507OMIM:605261HGNC:7891Uniprot:Q9NPH5AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NOX4 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NOX4 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
1
clinvar
3
missense
26
clinvar
1
clinvar
1
clinvar
28
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
1
clinvar
1
Total 0 0 26 3 3

Variants in NOX4

This is a list of pathogenic ClinVar variants found in the NOX4 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
11-89337490-T-C not specified Uncertain significance (Apr 07, 2022)2352441
11-89340101-G-A Benign (Jul 31, 2018)786601
11-89340125-C-T not specified Uncertain significance (Mar 24, 2023)2570149
11-89340134-A-G not specified Uncertain significance (Oct 25, 2023)3201449
11-89340134-A-T not specified Uncertain significance (Feb 11, 2022)2208685
11-89342087-G-C not specified Uncertain significance (Jun 17, 2024)3300537
11-89342199-G-A Benign (Apr 06, 2018)791177
11-89354977-G-T not specified Uncertain significance (Feb 14, 2023)3201448
11-89373486-T-C not specified Uncertain significance (Mar 25, 2024)3300533
11-89400055-C-T not specified Uncertain significance (Jun 01, 2023)2554619
11-89400225-C-A not specified Uncertain significance (Nov 12, 2021)2260623
11-89400283-T-C not specified Uncertain significance (Jun 30, 2023)2607179
11-89400316-G-A not specified Uncertain significance (Apr 11, 2023)2522175
11-89400337-C-T not specified Uncertain significance (Jul 26, 2022)2303207
11-89400338-G-C Benign (Aug 02, 2017)786208
11-89400364-A-C not specified Uncertain significance (May 04, 2022)2287290
11-89400368-C-A not specified Uncertain significance (Jun 29, 2023)2607943
11-89400368-C-G not specified Uncertain significance (Dec 11, 2023)3201451
11-89402500-G-A Likely benign (Apr 06, 2018)722792
11-89402530-C-A not specified Uncertain significance (Mar 14, 2023)2455688
11-89421913-C-A not specified Uncertain significance (Feb 14, 2023)2483612
11-89421953-G-A not specified Uncertain significance (Mar 20, 2024)3300534
11-89432820-A-G not specified Uncertain significance (Feb 07, 2023)2481795
11-89432829-A-G not specified Uncertain significance (Aug 10, 2021)2364586
11-89432830-C-A not specified Uncertain significance (Jul 25, 2023)2613757

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NOX4protein_codingprotein_codingENST00000263317 18265256
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
5.76e-200.02241256630851257480.000338
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.8983402961.150.00001443759
Missense in Polyphen9497.0190.968891252
Synonymous-3.371511071.410.000005161067
Loss of Function0.8573338.80.8510.00000213446

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0009730.000929
Ashkenazi Jewish0.000.00
East Asian0.0004020.000381
Finnish0.00009250.0000924
European (Non-Finnish)0.0001990.000193
Middle Eastern0.0004020.000381
South Asian0.001130.00111
Other0.0001640.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Constitutive NADPH oxidase which generates superoxide intracellularly upon formation of a complex with CYBA/p22phox. Regulates signaling cascades probably through phosphatases inhibition. May function as an oxygen sensor regulating the KCNK3/TASK-1 potassium channel and HIF1A activity. May regulate insulin signaling cascade. May play a role in apoptosis, bone resorption and lipolysaccharide-mediated activation of NFKB. May produce superoxide in the nucleus and play a role in regulating gene expression upon cell stimulation. Isoform 3 is not functional. Isoform 5 and isoform 6 display reduced activity.;
Pathway
AGE-RAGE signaling pathway in diabetic complications - Homo sapiens (human);Thyroid hormone synthesis;Angiogenesis overview;Spinal Cord Injury;Oxidative Stress;Detoxification of Reactive Oxygen Species;Cellular responses to stress;Cellular responses to external stimuli;Signaling events mediated by PTP1B (Consensus)

Recessive Scores

pRec
0.330

Intolerance Scores

loftool
0.0754
rvis_EVS
0.11
rvis_percentile_EVS
62.1

Haploinsufficiency Scores

pHI
0.200
hipred
Y
hipred_score
0.593
ghis
0.475

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.190

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Nox4
Phenotype
nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); growth/size/body region phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
cell morphogenesis;response to hypoxia;heart process;superoxide metabolic process;defense response;inflammatory response;cell aging;negative regulation of cell population proliferation;gene expression;positive regulation of smooth muscle cell migration;electron transport chain;cellular response to oxidative stress;superoxide anion generation;positive regulation of apoptotic process;positive regulation of MAP kinase activity;bone resorption;homocysteine metabolic process;positive regulation of stress fiber assembly;positive regulation of protein kinase B signaling;cardiac muscle cell differentiation;oxidation-reduction process;positive regulation of protein tyrosine kinase activity;positive regulation of ERK1 and ERK2 cascade;cellular response to cAMP;cellular response to glucose stimulus;cellular response to gamma radiation;cellular response to transforming growth factor beta stimulus;reactive oxygen species metabolic process;reactive oxygen species biosynthetic process;positive regulation of reactive oxygen species metabolic process;positive regulation of DNA biosynthetic process
Cellular component
stress fiber;nucleus;nucleolus;mitochondrion;endoplasmic reticulum membrane;plasma membrane;focal adhesion;integral component of membrane;apical plasma membrane;NADPH oxidase complex;perinuclear region of cytoplasm;perinuclear endoplasmic reticulum
Molecular function
nucleotide binding;protein binding;electron transfer activity;NAD(P)H oxidase activity;superoxide-generating NADPH oxidase activity;oxygen sensor activity;heme binding;flavin adenine dinucleotide binding;modified amino acid binding;protein tyrosine kinase binding